• Topics
    • Acute Care
    • Advocacy
    • Anatomy
    • Art & Science
    • Coffee Break
    • Case Studies
    • Continuing Education
    • Esophageal Dysphagia
    • Evidence Based Practice
    • Reflux
    • Head Neck Cancer
    • Instrumental Assessment
    • International
    • Neurogenic Dysphagia
    • Pediatric
    • Podcasts
    • Rehabilitation
    • Telepractice
  • Resources
  • ENRICHMENT WEBINARS
  • My account
  • 0 items
Search
  • Home
  • About
  • Contact
  • Disclaimer
  • My account
Dysphagia Cafe Dysphagia Cafe
  • Topics
    • Acute Care
    • Advocacy
    • Anatomy
    • Art & Science
    • Coffee Break
    • Case Studies
    • Continuing Education
    • Esophageal Dysphagia
    • Evidence Based Practice
    • Reflux
    • Head Neck Cancer
    • Instrumental Assessment
    • International
    • Neurogenic Dysphagia
    • Pediatric
    • Podcasts
    • Rehabilitation
    • Telepractice
  • Resources
  • ENRICHMENT WEBINARS
  • My account
  • 0 items

STAY CONNECTED

Facebook 19.7KFans
Twitter 5.2KFollowers
Instagram 11KFollowers

ENRICHMENT WEBINARS

  • Dysphagia Webinar Outpatient Managing a complex and variable caseload in the outpatient setting: How do clinicians keep up? $15.00
  • Rogus Pulia Dysphagia Webinar Dysphagia management in persons with Alzheimer’s Disease and Related Dementias $0.00

Scroll for Important Safety Information

INDICATIONS AND USAGE:

VARIBAR ® THIN HONEY (barium sulfate) oral suspension, VARIBAR ® NECTAR (barium sulfate) oral suspension, and VARIBAR ® THIN LIQUID (barium sulfate) for oral suspension, are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients. VARIBAR ® HONEY (barium sulfate) oral suspension and VARIBAR ® PUDDING (barium sulfate) oral paste are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients 6 months of age and older.

IMPORTANT SAFETY INFORMATION:
For Oral Administration. This product should not be used in patients with known or suspected perforation of the GI tract, known obstruction of the GI tract, high risk of aspiration, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Aspiration may occur during the modified barium swallow examination, monitor the patient for aspiration.

Please consult full Prescribing Information for VARIBAR products by clicking HERE.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit FDA or call 1-800-FDA-1088.

Lisa Evangelista Webinar ad
Dysphagia Cafe logo

Dysphagia Café’s mission is to be a quality, consistent, reliable and easily accessible resource community for every dysphagia clinician worldwide. This is achieved by generating and promoting original evidence-based content by global leaders in dysphagia research and practice.

© Dysphagia Cafe